Composition
- Active ingredients
- PROCAINAMIDE HYDROCHLORIDE 375MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PROCAINAMIDE HYDROCHLORIDE 375MG · TabletThis page
- PROCAINAMIDE HYDROCHLORIDE 500MG · TabletNDA017371-003 · Discontinued
- PROCAINAMIDE HYDROCHLORIDE 250MG · TabletNDA017371-001 · Discontinued
- PROCAINAMIDE HYDROCHLORIDE 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA007335-001 · Discontinued
- PROCAINAMIDE HYDROCHLORIDE 375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA007335-004 · Discontinued
- PROCAINAMIDE HYDROCHLORIDE 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA007335-002 · Discontinued
- PROCAINAMIDE HYDROCHLORIDE 500MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA007335-005 · Discontinued
- PROCAINAMIDE HYDROCHLORIDE 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA007335-003 · Discontinued
Official product information
At a glance
- Brand name
- Pronestyl
- Active substance
- procainamide hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Apothecon
- Status
- Discontinued
- FDA approval
- 28 Feb 1974
- Application
- NDA017371-002